Follow
UPMA DAVE
UPMA DAVE
Scientific affairs associate at Hyloris Pharmaceuticals
No verified email
Title
Cited by
Cited by
Year
Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients
P Narain, AK Padhi, U Dave, D Mishra, R Bhatia, P Vivekanandan, ...
Neurogenetics 20, 197-208, 2019
212019
Insights into the role of ribonuclease 4 polymorphisms in amyotrophic lateral sclerosis
AK Padhi, P Narain, U Dave, R Satija, A Patir, J Gomes
Journal of Biomolecular Structure and Dynamics 37 (1), 116-130, 2019
102019
High-mobility group box 1 protein promotes dengue virus replication by interacting with untranslated regions of viral genome
N Chaudhary, S Srivastava, U Dave, A Ojha, P Guchhait, A Chandele, ...
Virus Research 309, 198668, 2022
72022
Characterization of E121K mutation of D-amino acid oxidase–insights into mechanisms leading to amyotrophic lateral sclerosis
U Dave, S Khan, J Gomes
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1871 (6), 140947, 2023
32023
Aggregation of E121K mutant D-amino acid oxidase and ubiquitination-mediated autophagy mechanisms leading to amyotrophic lateral sclerosis
U Dave, P Narain, D Mishra, J Gomes
Journal of the Neurological Sciences 456, 122845, 2024
2024
Structural and mechanistic insights into ALS patient derived mutations in D-amino acid oxidase
S Khan, S Upadhyay, U Dave, A Kumar, J Gomes
International Journal of Biological Macromolecules 256, 128403, 2024
2024
Role of ALS-associated OPTN-K489E mutation in neuronal cell-death regulation
D Mishra, P Narain, U Dave, J Gomes
Molecular and Cellular Neuroscience 127, 103904, 2023
2023
Role of E121K mutation of D-amino acid oxidase in amyotrophic lateral sclerosis
U Dave
IIT Delhi, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–8